Other languages Crescita Therapeutics Inc.

Equities

CTX

CA2258471028

Market Closed - Toronto S.E. Other stock markets 12:59:15 2024-05-09 EDT			5-day change	1st Jan Change
0.435 ^CAD	0.00%		+1.16%	-11.22%

05-08	Crescita Therapeutics Q1 Loss Widens, Revenue Rises	MT
05-08	Crescita Therapeutics Brief: Q1 Revenue was $4.996 Million	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Crescita Therapeutics Q1 Loss Widens, Revenue Rises	05-08
Crescita Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08
Crescita Therapeutics Reports Q4 Net Loss of $0.01 Per Share	03-13
Crescita Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-13
Crescita Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-13
Crescita Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08
Crescita Therapeutics Inc. announces an Equity Buyback for 1,821,616 shares, representing 8.94% of its issued share capital.	23-08-29
Crescita Therapeutics Inc. authorizes a Buyback Plan.	23-08-28
Crescita Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09
Crescita Therapeutics Inc. Announces Launch of Topical Anaesthetic Pliaglis(R) in Europe in Its European Core Markets Including Germany, the United Kingdom and Ireland	23-06-01
Crescita Therapeutics Q1 Revenue was $4.6 Million; Cites Cash Balance of $10.3M	23-05-11
Crescita Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
Crescita Therapeutics Reports Q4 Revenue of $6.03 Million, EPS of $0.06	23-03-15
Crescita Therapeutics Inc. acquired unknown minority stake in Akyucorp Ltd. for CAD 0.06 million.	23-03-14
Crescita Therapeutics Reports Q3 Revenue of $6 Million; EPS C$0.01; Cash Balance of $10.7 Million	22-11-09
Crescita Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09
Crescita Therapeutics Reports Q2 Revenue of $6.5 Million	22-08-10
Crescita Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-10
Crescita Therapeutics Q1 Loss of $0.02 Per Share	22-05-11
Crescita Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Crescita Therapeutics Inc.

Equities

CTX

CA2258471028

Other languages

Filters